Spyre Therapeutics Inc.

NASDAQ: SYRE · Real-Time Price · USD
16.93
0.07 (0.42%)
At close: Aug 15, 2025, 3:59 PM
16.95
0.12%
After-hours: Aug 15, 2025, 07:36 PM EDT

Spyre Therapeutics Revenue

Spyre Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2025, Spyre Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
73
Market Cap
1.02B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.